You are here: Industry Insights > SARS-CoV-2

News List

EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variants prnasia
December 01, 2021
Today EpiVax, Inc. ("EpiVax") confirmed that the company's EPV-CoV-19 vaccine epitopes are 98.2% conserved in the new Omicron SARS-CoV-2 variant. EpiVax and EpiVax Therapeutics, Inc. ("EVT")...
GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan prnasia
December 01, 2021
GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture, Japan...
Exposure to harmless coronaviruses boosts SARS-CoV-2 immunity WorldPharmaNews
December 01, 2021
The population's immunity to SARS-CoV-2, achieved either through infection or vaccination, is crucial to overcome the COVID-19 pandemic. A team of researchers led by the University of Zurich (UZH) has now discovered another component that contributes...
JOYSBIO's SARS-COV-2 Antigen Rapid test detects OMICRON variant prnasia
November 30, 2021
JOYSBIO, one of the world's leading manufacturers of lateral flow rapid tests, is proud to announce that their tests are available around the world.
Biotron Drug Effective Against COVID-19 In Animals prnewswire
November 26, 2021
The Directors of Biotron Limited (ASX: BIT) are pleased to announce that the Company's lead clinical asset, BIT225, has demonstrated substantial and clinically meaningful efficacy against SARS-CoV-2 in a series...
Seqirus Announces U.S. FDA Approval for Multi-Dose Vial Presentation of First-Ever Adjuvanted, Cell-Based Pandemic Influenza Vaccine prnewswire
November 25, 2021
iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens, today announced that it has been contracted to support new advanced research on COVID-19...
Vela Diagnostics expands automation options for SARS-CoV-2 RT-PCR Test prnasia
November 22, 2021
Vela Diagnostics announced today that the ViroKey® SARS-CoV-2 RT-PCR Test v2.0 that received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)...
Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics ExpressPharma
November 19, 2021
Twist Bioscience Corporation has launched Revelar Biotherapeutics, Inc., an independently operated, new biotechnology company to develop and commercialize an antibody...
Repurposing a familiar drug for COVID-19 WorldPharmaNews
November 18, 2021
For the past year and a half, the COVID-19 pandemic has continued to engulf the globe, fueled in part by novel variants and the uneven distribution of vaccines.
NII says Covaxin has cellular immune memory to COVID for at least six months ExpressPharma
November 17, 2021
Covaxin has immunological memory to SARS-CoV-2 and its variants of concern for at least up to six months, Pushkar Sharma, Director in-Charge, National Institute of Immunology (NII) said...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page